Renal cell carcinoma in children: the results of retrospective analysis

L. A. Smirnova, A. Mitrofanova, N. Merkulov, M. Teleshova, D. Akhaladze, N. Uskova, A. Shapochnik, M. Rakov, A. A. Rumyantsev, I. Fisyun, D. Sakun, G. R. Kazaryan, A. P. Troitskaya, E. Erega, E. Bogatyreva, V. B. Makhonin, M. Borisova, I. V. Osipova, I. N. Skapenkov, N. S. Grachev, T. Shamanskaya, D. Konovalov, D. Kachanov
{"title":"Renal cell carcinoma in children: the results of retrospective analysis","authors":"L. A. Smirnova, A. Mitrofanova, N. Merkulov, M. Teleshova, D. Akhaladze, N. Uskova, A. Shapochnik, M. Rakov, A. A. Rumyantsev, I. Fisyun, D. Sakun, G. R. Kazaryan, A. P. Troitskaya, E. Erega, E. Bogatyreva, V. B. Makhonin, M. Borisova, I. V. Osipova, I. N. Skapenkov, N. S. Grachev, T. Shamanskaya, D. Konovalov, D. Kachanov","doi":"10.21682/2311-1267-2023-10-2-11-27","DOIUrl":null,"url":null,"abstract":"Introduction. Renal cell carcinoma (RCC) is a rare malignant renal tumor in children, which accounts for 2–4 % of pediatric and adolescent’s kidney malignancies. A number of recent studies have shown that RCC developing in pediatric age differs in the spectrum of histological variants, clinical course and prognosis from RCC in adult patients.The aim of the study – retrospective analysis of the clinical and morphological characteristics of RCC, as well as the results of therapy of patients with a diagnosis verified in the Department of Pathology in Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia (Center).Materials and methods. Retrospective analysis of patients with a histologically confirmed diagnosis RCC for the period 01.2012–05.2022 was done. During the specified period of time in the Department of Pathology in Center 42 patients with a confirmed diagnosis of RCC aged 0 to 18 years were registered. Out of 42 registered patients with RСС, 28 patients with known clinical data were included in this analysis, of which 11 patients underwent primary surgical treatment in Center. Demographic characteristics, clinical data, morphological variants of RCC, the volume of therapy performed, including the features of the performed surgical intervention were analyzed. The assessment of stage was carried out according to the TNM classification. Patients were treated according to the protocols of the SIOP-RTSG group (SIOP 93-01, SIOP-2001, SIOP-RTSG-2016). The analysis of the results was carried out on 01.06.2022.Results. In the general group of patients (n = 42), the distribution by histological types was presented as follows: papillary type – in 16/42 (38.0 %), translocation type – in 12/42 (28.6 %), clear cell type – in 5/42 (11.9 %), chromophobic type – in 4/42 (9.5 %), RCC with succinate dehydrogenase deficiency – in 2/42 (4.8 %), translocation type in combination with papillary type – in 1/42 (2.4 %), tubulocystic type – in 1/42 (2.4 %), unspecified type – in 1/42 (2.4 %). A subsequent in-depth analysis was performed on a group of 28 patients. The median age at the time of diagnosis of RCC was 11.0 years (range – 3.0–16.9). The male:female ratio was 1.1:1. The median tumor volume (n = 27) was 44 cm3 (range 1.8–547.7 cm3 ). The clinical picture included palpable formation in the abdominal cavity (n = 5), intoxication syndrome (n = 5), pain (n = 4), enuresis (n = 1), macrohematuria (n = 1), in 12 cases the tumor was detected accidentally. The duration from the onset of the first symptoms/detection of the tumor to the diagnosis was 2.5 months (range 0.5–40.3 months). Distribution by clinical stages according to the TNM system: stage T1 – 22 (78.5 %) cases, T2 – 4 (14.3 %) cases, T3 – 1 (3.6 %), Tx – 1 (3.6 %) case. According to the results of postsurgical staging, the following distribution by stages N was noted: N0 – 15 (53.6 %) cases, N1 – 4 (14.3 %) cases, Nx – 9 (32.1 %) cases. Stage M0 – in 22 (79 %) patients, 6 (21 %) patients were not fully examined, the stage was treated as Mx, mainly due to the lack of data on osteoscintigraphy. It should be noted that proven distant metastases were not detected in any patient at the time of diagnosis. Preoperative polychemotherapy (PCT) without histological verification was performed in 9 (32.1 %) patients. When assessing the size of the tumor after preoperative PCT, a decrease in size was noted in 2 patients, the absence of size dynamics in 7 patients. Surgical treatment was performed in all patients. An initial thick-needle biopsy followed by surgery was performed in 6 (21.4 %) patients, 1 (3.6 %) patient underwent an initial laparoscopic biopsy of the affected retroperitoneal lymph node. In 1 (3.6 %) case, a biopsy was performed followed by chemotherapy. In 3 cases, the biopsy was uninformative and in 2 cases a second biopsy was performed. The primary surgery was performed in 11 (39.3 %) patients. R0 resection was achieved in 22 (78.6 %) cases, R1 resection was proved in 2 (7.1 %) cases, in 4 (14.3 %) cases the resection edges were not subject to evaluation (Rx). In 2 cases, complications of surgical treatment were noted: in 1 case, intraoperative tumor rupture, in 1 case – ischemic nephropathy after laparoscopic kidney resection. All patients were diagnosed morphologically in Center. Translocation RCC – 9 (32.1 %) cases and papillary RCC – 9 (32.1 %) cases prevailed in the group of 28 patients. The discrepancy of diagnoses/histological subtypes of RCC between the local pathomorphological laboratory and the reference in Center were noted in 7 (25 %) cases. The median follow–up of patients was 15.9 months (range 0.4–78.0 months). Of the 28 patients, 26 are alive (92.8 %). The progression of the disease was observed in 2 cases with the development of distant metastases in 1.6 and 12.8 months, these patients died.Conclusion. RCC is a rare type of kidney tumor in children. Papillary and translocation variants of PCC are prevalent in the pediatric population. At the moment, radical nephrectomy with mandatory morphological examination of regional lymph nodes is considered as a standard treatment, while in some cases an organ-preserving operation may be considered. Interdisciplinary discussion of management tactics and surgical treatment in centers specializing in pediatric oncourology is mandatory.","PeriodicalId":52396,"journal":{"name":"Russian Journal of Pediatric Hematology and Oncology","volume":"13 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Russian Journal of Pediatric Hematology and Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21682/2311-1267-2023-10-2-11-27","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction. Renal cell carcinoma (RCC) is a rare malignant renal tumor in children, which accounts for 2–4 % of pediatric and adolescent’s kidney malignancies. A number of recent studies have shown that RCC developing in pediatric age differs in the spectrum of histological variants, clinical course and prognosis from RCC in adult patients.The aim of the study – retrospective analysis of the clinical and morphological characteristics of RCC, as well as the results of therapy of patients with a diagnosis verified in the Department of Pathology in Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia (Center).Materials and methods. Retrospective analysis of patients with a histologically confirmed diagnosis RCC for the period 01.2012–05.2022 was done. During the specified period of time in the Department of Pathology in Center 42 patients with a confirmed diagnosis of RCC aged 0 to 18 years were registered. Out of 42 registered patients with RСС, 28 patients with known clinical data were included in this analysis, of which 11 patients underwent primary surgical treatment in Center. Demographic characteristics, clinical data, morphological variants of RCC, the volume of therapy performed, including the features of the performed surgical intervention were analyzed. The assessment of stage was carried out according to the TNM classification. Patients were treated according to the protocols of the SIOP-RTSG group (SIOP 93-01, SIOP-2001, SIOP-RTSG-2016). The analysis of the results was carried out on 01.06.2022.Results. In the general group of patients (n = 42), the distribution by histological types was presented as follows: papillary type – in 16/42 (38.0 %), translocation type – in 12/42 (28.6 %), clear cell type – in 5/42 (11.9 %), chromophobic type – in 4/42 (9.5 %), RCC with succinate dehydrogenase deficiency – in 2/42 (4.8 %), translocation type in combination with papillary type – in 1/42 (2.4 %), tubulocystic type – in 1/42 (2.4 %), unspecified type – in 1/42 (2.4 %). A subsequent in-depth analysis was performed on a group of 28 patients. The median age at the time of diagnosis of RCC was 11.0 years (range – 3.0–16.9). The male:female ratio was 1.1:1. The median tumor volume (n = 27) was 44 cm3 (range 1.8–547.7 cm3 ). The clinical picture included palpable formation in the abdominal cavity (n = 5), intoxication syndrome (n = 5), pain (n = 4), enuresis (n = 1), macrohematuria (n = 1), in 12 cases the tumor was detected accidentally. The duration from the onset of the first symptoms/detection of the tumor to the diagnosis was 2.5 months (range 0.5–40.3 months). Distribution by clinical stages according to the TNM system: stage T1 – 22 (78.5 %) cases, T2 – 4 (14.3 %) cases, T3 – 1 (3.6 %), Tx – 1 (3.6 %) case. According to the results of postsurgical staging, the following distribution by stages N was noted: N0 – 15 (53.6 %) cases, N1 – 4 (14.3 %) cases, Nx – 9 (32.1 %) cases. Stage M0 – in 22 (79 %) patients, 6 (21 %) patients were not fully examined, the stage was treated as Mx, mainly due to the lack of data on osteoscintigraphy. It should be noted that proven distant metastases were not detected in any patient at the time of diagnosis. Preoperative polychemotherapy (PCT) without histological verification was performed in 9 (32.1 %) patients. When assessing the size of the tumor after preoperative PCT, a decrease in size was noted in 2 patients, the absence of size dynamics in 7 patients. Surgical treatment was performed in all patients. An initial thick-needle biopsy followed by surgery was performed in 6 (21.4 %) patients, 1 (3.6 %) patient underwent an initial laparoscopic biopsy of the affected retroperitoneal lymph node. In 1 (3.6 %) case, a biopsy was performed followed by chemotherapy. In 3 cases, the biopsy was uninformative and in 2 cases a second biopsy was performed. The primary surgery was performed in 11 (39.3 %) patients. R0 resection was achieved in 22 (78.6 %) cases, R1 resection was proved in 2 (7.1 %) cases, in 4 (14.3 %) cases the resection edges were not subject to evaluation (Rx). In 2 cases, complications of surgical treatment were noted: in 1 case, intraoperative tumor rupture, in 1 case – ischemic nephropathy after laparoscopic kidney resection. All patients were diagnosed morphologically in Center. Translocation RCC – 9 (32.1 %) cases and papillary RCC – 9 (32.1 %) cases prevailed in the group of 28 patients. The discrepancy of diagnoses/histological subtypes of RCC between the local pathomorphological laboratory and the reference in Center were noted in 7 (25 %) cases. The median follow–up of patients was 15.9 months (range 0.4–78.0 months). Of the 28 patients, 26 are alive (92.8 %). The progression of the disease was observed in 2 cases with the development of distant metastases in 1.6 and 12.8 months, these patients died.Conclusion. RCC is a rare type of kidney tumor in children. Papillary and translocation variants of PCC are prevalent in the pediatric population. At the moment, radical nephrectomy with mandatory morphological examination of regional lymph nodes is considered as a standard treatment, while in some cases an organ-preserving operation may be considered. Interdisciplinary discussion of management tactics and surgical treatment in centers specializing in pediatric oncourology is mandatory.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
儿童肾细胞癌:回顾性分析结果
介绍。肾细胞癌(RCC)是一种罕见的儿童肾恶性肿瘤,占儿童和青少年肾恶性肿瘤的2 - 4%。最近的一些研究表明,儿童年龄的RCC在组织学变异谱、临床病程和预后方面与成人患者的RCC有所不同。本研究的目的是回顾性分析RCC的临床和形态学特征,以及在俄罗斯卫生部Dmitry Rogachev国家儿童血液学、肿瘤学和免疫学医学研究中心(中心)病理科室确诊的患者的治疗结果。材料和方法。回顾性分析2012年1月至2022年5月期间组织学确诊为RCC的患者。在指定的时间内,在中心的病理部门登记了42例确诊为RCC的患者,年龄在0到18岁之间。在42例登记的RСС患者中,28例已知临床资料的患者纳入本分析,其中11例患者在中心接受了初级手术治疗。分析了RCC的人口统计学特征、临床资料、形态学变异、治疗量,包括手术干预的特点。根据TNM分级进行阶段评价。患者按照SIOP- rtsg组方案(SIOP 93-01、SIOP-2001、SIOP- rtsg -2016)进行治疗。结果分析于2022年6月1日进行。一般组患者(n = 42),通过组织学类型提出了分布如下:乳头状型——在16/42(38.0%)、易位型——在12/42(28.6%),明显的细胞类型,在5/42(11.9%)、chromophobic类型——在4/42(9.5%)、碾压混凝土与琥珀酸脱氢酶缺乏症在2/42(4.8%)、易位型结合乳头状型——在1/42(2.4%)、tubulocystic类型——在1/42(2.4%),未指明的那种类型,1/42(2.4%)。随后对28名患者进行了深入分析。诊断为RCC时的中位年龄为11.0岁(范围- 3.0-16.9)。男女比例为1.1:1。中位肿瘤体积(n = 27)为44 cm3(范围1.8-547.7 cm3)。临床表现为可触及腹腔内形成物(5例)、中毒综合征(5例)、疼痛(4例)、遗尿(1例)、大量血尿(1例),其中意外发现肿瘤12例。从首次出现症状/发现肿瘤到诊断的时间为2.5个月(0.5-40.3个月)。TNM分级临床分期分布:T1 ~ 22例(78.5%),T2 ~ 4例(14.3%),T3 ~ 1例(3.6%),Tx ~ 1例(3.6%)。根据术后分期结果,N期分布如下:N0 ~ 15例(53.6%),N1 ~ 4例(14.3%),Nx ~ 9例(32.1%)。M0期:22例(79%)患者,6例(21%)患者未进行充分检查,主要由于缺乏骨显像资料,该期被视为Mx期。值得注意的是,在诊断时没有发现任何患者的远处转移。9例(32.1%)患者术前未经组织学证实行多化疗(PCT)。术前PCT后评估肿瘤大小时,2例患者体积减小,7例患者体积无变化。所有患者均行手术治疗。6例(21.4%)患者在手术后进行了初始粗针活检,1例(3.6%)患者接受了受影响的腹膜后淋巴结的初始腹腔镜活检。1例(3.6%)患者在化疗后行活检。在3例中,活检没有提供信息,2例进行了第二次活检。11例(39.3%)患者行首次手术。R0切除22例(78.6%),R1切除2例(7.1%),4例(14.3%)切除边缘不需要评估(Rx)。2例出现手术并发症:1例术中肿瘤破裂,1例腹腔镜肾切除术后缺血性肾病。所有患者均在中心进行形态学诊断。28例患者中以易位型RCC - 9(32.1%)和乳头状型RCC - 9(32.1%)为主。7例(25%)当地病理实验室与中心参考的RCC诊断/组织学亚型存在差异。患者的中位随访时间为15.9个月(0.4-78.0个月)。在28例患者中,26例存活(92.8%)。2例患者病情进展,在1.6个月和12.8个月发生远处转移,死亡。肾细胞癌是一种罕见的儿童肾肿瘤。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Russian Journal of Pediatric Hematology and Oncology
Russian Journal of Pediatric Hematology and Oncology Medicine-Pediatrics, Perinatology and Child Health
CiteScore
0.40
自引率
0.00%
发文量
36
期刊最新文献
Pilot clinical trial of DNA vaccination against neuroblastoma: study design and preliminary results The relevance of genetic testing in young patients with breast fibroadenomas Molecular biology techniques for assessing the loss of HLA heterozygosity after allogeneic hematopoietic stem cell transplantation in children with acute leukemia Complications after pylori-preserving pancreatoduodenal resection in a 14-year-old girl with a solid pseudopapillary tumor of the pancreas Familial DICER1 syndrome with thyroid pathology. A series of clinical cases
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1